Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Shareholders Equity (Quarterly) : 24.52M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.52M |
| March 31, 2026 | 98.73M |
| December 31, 2025 | 114.83M |
| September 30, 2025 | 73.56M |
| June 30, 2025 | 32.75M |
| March 31, 2025 | 32.82M |
| December 31, 2024 | 59.08M |
| September 30, 2024 | -30.45M |
| June 30, 2024 | 15.15M |
| March 31, 2024 | 74.07M |
| December 31, 2023 | 200.81M |
| September 30, 2023 | 279.77M |
| June 30, 2023 | 116.48M |
| March 31, 2023 | 189.14M |
| December 31, 2022 | 42.85M |
| September 30, 2022 | 100.68M |
| June 30, 2022 | 156.71M |
| March 31, 2022 | 208.14M |
| December 31, 2021 | 302.11M |
| September 30, 2021 | 307.37M |
| June 30, 2021 | 332.30M |
| March 31, 2021 | 362.69M |
| December 31, 2020 | 211.21M |
| September 30, 2020 | 301.41M |
| June 30, 2020 | 318.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 225.75M |
| December 31, 2019 | 221.20M |
| September 30, 2019 | 245.96M |
| June 30, 2019 | 277.09M |
| March 31, 2019 | 285.71M |
| December 31, 2018 | 318.25M |
| September 30, 2018 | 319.06M |
| June 30, 2018 | 287.99M |
| March 31, 2018 | 299.48M |
| December 31, 2017 | 293.13M |
| September 30, 2017 | 304.52M |
| June 30, 2017 | 295.83M |
| March 31, 2017 | 300.94M |
| December 31, 2016 | 307.77M |
| September 30, 2016 | 307.60M |
| June 30, 2016 | 314.37M |
| March 31, 2016 | 319.23M |
| December 31, 2015 | 299.97M |
| September 30, 2015 | 291.01M |
| June 30, 2015 | 150.78M |
| March 31, 2015 | 168.57M |
| December 31, 2014 | -37.25M |
| September 30, 2014 | -10.19M |
| June 30, 2014 | 1.067M |
| March 31, 2014 | -35.39M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Insmed, Inc. | 757.49M |
| United Therapeutics Corp. | 6.400B |
| Krystal Biotech, Inc. | 1.359B |
| Relay Therapeutics, Inc. | 890.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 799.36M |
| Total Liabilities (Quarterly) | 774.84M |
| Debt to Equity Ratio | 25.16 |
| Current Ratio | 4.046 |
| Net Debt Paydown Yield | -0.81% |